GBA1 and Parkinson disease: These findings partially contradict previous studies that did not report GCase substrate accumulation in the brain of PD patients with heterozygote GBA1 mutations or iPD patients with reduced GCase activity (Murphy et al., 2014; Gegg et al., 2015).